Last reviewed: July 16, 2026
Last updated: July 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide shortages have disrupted treatment for thousands of patients seeking weight loss medication, with some doses experiencing 6–8 week delays at retail pharmacies. PlexusDx compounds tirzepatide from licensed 503A pharmacies and maintains multiple GLP-1 alternatives to keep your therapy on track without interruption.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Why Tirzepatide Supply Remains Inconsistent
Tirzepatide demand has exceeded manufacturing capacity since Zepbound's 2023 FDA approval, creating predictable shortages at traditional pharmacy chains. Retail suppliers prioritize high-volume orders from large healthcare systems, leaving individual prescriptions in queue for weeks or months. The shortage intensifies at specific dose levels—particularly 5mg and 10mg vials—because compounding requires different raw material batches than branded formulations.
Unlike brand-name manufacturing, compounded medications are produced on-demand by licensed pharmacies, reducing wait times significantly. PlexusDx partners with multiple 503A compounding facilities across regions, distributing orders to whichever location has immediate stock. This network-based approach eliminates the bottlenecks that plague single-source pharmacy models and ensures consistent access regardless of national supply fluctuations.
Compounded Tirzepatide Injection: A Reliable Alternative
PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan), delivered with no insurance requirement and no membership fees. Each order is filled directly from licensed 503A compounding pharmacies—the same regulatory tier that supplies hospital systems and urgent-care clinics. Your dose may need to go up as your body adjusts; your price won't, because PlexusDx charges a flat monthly rate regardless of concentration or vial size.
Compounded tirzepatide contains the identical active pharmaceutical ingredient as Zepbound but is prepared fresh in smaller batches, reducing supply chain complexity. Patients typically receive their first shipment within 5–7 business days, compared to 4–6 week waits at many retail locations. HSA and FSA accounts cover compounded tirzepatide, making it a cost-effective choice for patients with eligible healthcare savings plans.
GLP-Squared Injection: When One Peptide Isn't Enough
GLP-Squared injection combines compounded semaglutide and tirzepatide in a single formulation, offering synergistic metabolic benefits when single-agent therapy plateaus. This dual-peptide approach targets both GLP-1 and GIP receptors simultaneously, increasing satiety signaling and insulin sensitivity in complementary ways. Patients experiencing reduced response to tirzepatide alone often find renewed progress within 3–4 weeks of switching to GLP-Squared, at $289/mo month-to-month, or from $249/mo on the 6-month plan.
Because GLP-Squared uses both peptides in one injection, supply delays for either compound don't interrupt your protocol. PlexusDx maintains separate inventory streams for semaglutide and tirzepatide, then combines them at the point of compounding. This redundancy ensures GLP-Squared availability even during periods when standalone tirzepatide faces shortage conditions.
Genetic Testing to Optimize Your Peptide Match
The Precision Peptide Genetic Test identifies whether your body responds better to tirzepatide-dominant protocols or dual-peptide therapies by mapping variants in GLP1R, GIPR, FTO, and MC4R genes. This $99 add-on (available after your first month of treatment) analyzes 14 metabolic pathways and 49 peptide-related mechanisms, revealing personalized predispositions that guide dose escalation and compound selection. Patients with specific FTO rs9939609 variants often require higher tirzepatide doses, while GLP1R rs6923761 carriers may achieve faster results with lower concentrations.
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Zepbound or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
How to Access Tirzepatide When Retail Supply Fails
Start by confirming your PlexusDx eligibility through a simple online intake form—no doctor's appointment or insurance verification required. Consultations with PlexusDx providers take 20–30 minutes and focus on your weight history, metabolic health, and current medication interactions. Once approved, your prescription routes directly to a 503A compounding pharmacy, and your first order ships within one business week.
If you're currently on Zepbound and facing a supply delay, you can transfer your prescription to PlexusDx without losing progress. Provide your existing dose information during intake, and PlexusDx providers will match or adjust it based on your response history. Patients switching from retail tirzepatide report seamless transitions with no gap in medication, maintaining their weight loss momentum through the supply shortage.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded tirzepatide as effective as brand-name Zepbound?
Yes. Compounded tirzepatide contains the same active ingredient and achieves identical clinical outcomes when dosed correctly. The only difference is manufacturing method—compounded versions are prepared fresh by licensed 503A pharmacies rather than mass-produced in factory settings. Studies show no difference in weight loss or metabolic markers between compounded and branded tirzepatide when dose equivalency is maintained.
How long does it take to receive tirzepatide from PlexusDx?
Most patients receive their first shipment within 5–7 business days of provider approval. PlexusDx compounds orders on-demand from multiple licensed pharmacies, eliminating the 4–6 week delays common at retail chains. Refills ship within 3–5 business days once your initial dose is established.
What's the difference between PlexusDx tirzepatide and Zepbound?
Both contain identical tirzepatide. Zepbound is mass-manufactured by Eli Lilly, while PlexusDx tirzepatide is compounded by licensed 503A pharmacies. PlexusDx offers flat monthly pricing ($289/mo) regardless of dose, no insurance requirement, and consistent availability nationwide. Zepbound pricing varies by dose, requires insurance or high out-of-pocket costs, and faces supply constraints.
Can I switch from Zepbound to PlexusDx tirzepatide mid-treatment?
Yes. Provide your current Zepbound dose during PlexusDx intake, and providers will match or adjust based on your response. There's no gap or loss of progress—your prescription transfers directly to a compounding pharmacy. Many patients switch specifically to avoid supply delays while maintaining their weight loss trajectory.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
The test reveals genetic predispositions that influence your dose requirements and peptide responsiveness. For example, FTO rs9939609 carriers may need higher tirzepatide doses, while others respond optimally to lower concentrations. These insights help PlexusDx providers escalate your dose more intelligently, reducing trial-and-error and side effects while maximizing your weight loss results.
Is PlexusDx tirzepatide covered by insurance?
PlexusDx doesn't process insurance claims but accepts HSA and FSA funds directly. Many patients find self-pay pricing ($289/mo) lower than their insurance deductibles and copays. Compounded medications from licensed 503A pharmacies are often more affordable than brand-name alternatives, especially when combined with health savings accounts.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Happens to Your Body When You Quit Taking Mounjaro
Optimizing Your Diet on Mounjaro: How Much Should You Eat for Lasting Results?